Cargando…
Leukemia treatment in severe combined immunodeficiency mice by antisense oligodeoxynucleotides targeting cooperating oncogenes
Transformation of hematopoietic cells by the p210bcr/abl tyrosine kinase appears to require the expression of a functional MYC protein, suggesting that simultaneous targeting of BCR-ABL and c-myc might be a rational strategy for attempting treatment of Phil-adelphia leukemia. To test this hypothesis...
Formato: | Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1995
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2192227/ https://www.ncbi.nlm.nih.gov/pubmed/7500009 |
Ejemplares similares
-
The use of synthetic polymers for delivery of therapeutic antisense oligodeoxynucleotides
por: Chirila, Traian V, et al.
Publicado: (2002) -
Antisense oligodeoxynucleotides targeting ATM strengthen apoptosis of laryngeal squamous cell carcinoma grown in nude mice
por: Feng, Jun, et al.
Publicado: (2011) -
Photomodulating RNA cleavage using photolabile circular antisense oligodeoxynucleotides
por: Tang, XinJing, et al.
Publicado: (2010) -
Fundamental differences in the equilibrium considerations for siRNA and antisense oligodeoxynucleotide design
por: Lu, Zhi John, et al.
Publicado: (2008) -
Growth factor-dependent inhibition of normal hematopoiesis by N-ras antisense oligodeoxynucleotides
Publicado: (1992)